Escherichia coli resistant to ampicillin/sulbactam

Area of Science:

• Microbiology
• Molecular Biology
• Antimicrobial Resistance

Background:

• Ampicillin/sulbactam is a crucial antibiotic for treating infections.
• Emergence of resistant bacterial strains poses a significant public health threat.
• Understanding resistance mechanisms is vital for effective treatment strategies.

Purpose of the Study:

• To investigate the mechanisms of ampicillin/sulbactam resistance in clinical isolates of Escherichia coli.
• To characterize the beta-lactamase enzymes produced by resistant strains.
• To determine the role of plasmids in the transfer of resistance.

Main Methods:

• Analysis of beta-lactamase production in resistant and susceptible E. coli strains.
• Isoelectric focusing and kinetic analysis (Km, Vmax) of beta-lactamases.
• Plasmid DNA quantification and characterization.
• Plasmid-mediated transformation experiments.

Main Results:

• All resistant strains produced TEM-1 beta-lactamase with kinetic properties similar to controls.
• Highly resistant isolates produced significantly more beta-lactamase than susceptible ones.
• Resistance and its degree were transferable via plasmids, which were present in similar amounts in both resistant and susceptible strains.

Conclusions:

• The primary mechanism for ampicillin/sulbactam resistance in these E. coli isolates is the overproduction of TEM-1 beta-lactamase.
• This overproduction likely results from altered gene expression control or increased gene copy number on plasmids.
• Plasmid-mediated transfer facilitates the spread of resistance within bacterial populations.